Jan Phillipp Bewersdorf

79PUBLICATIONS
134CO-AUTHORS
Gene and molecular therapyRegenerative medicine (incl. stem cells)Haematological tumoursMetabolic medicinePredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (79)

|Jun 29, 2026
Outcomes of patients with higher-risk myelodysplastic syndromes/neoplasms treated with hypomethylating agents + venetoclax-an analysis from the International Consortium for MDS (icMDS) VALIDATE database.

|Jun 07, 2026
Menin inhibitors for patients with relapsed/refractory acute myeloid leukemia (AML): a systematic review and meta-analysis.

|Apr 25, 2026
Acute myeloid leukemia after myeloproliferative neoplasms: Real-world outcomes in the new treatment era in the United States.

|Apr 14, 2026
A 2026 update on myelodysplastic neoplasms: current state, challenges and future directions.

Jan Philipp Bewersdorf, Alain Mina, Maximilian Stahl

|Mar 25, 2026
Metabolic dysfunction-associated steatotic liver disease and acute leukemias - a literature review and future directions.

Tareq Salah, Maximillian Stahl, Jan Philipp Bewersdorf

|Feb 28, 2026
Learning from late-stage trial failures in higher-risk myelodysplastic syndromes: towards adaptive and biomarker-enriched designs.

Amer M Zeidan, Sofia Aakko, Maximilian Stahl

Pageof 14

Frequent Collaborators

24 joint publications

Rory Shallis

7 joint publications

Amer M Zeidan

6 joint publications

Talha Badar

5 joint publications

Nikolai Podoltsev